2023 Sponsors & Exhibitors

Sanofi is an innovative global healthcare company, driven by one purpose: chasing the miracles of science to improve people’s lives. We transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people. For more information please visit www.sanofi.com

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. To learn more, please visit www.astrazeneca.com

As a partner of choice for the pharmaceutical and biotech companies across the globe, BD Medical - Pharmaceutical Systems provides a broad range of parenteral drug delivery systems including glass and plastic prefillable syringes, safety and shielding systems as well as advanced drug delivery solutions that help ensure smooth delivery considering drug complexity, viscosity and dosing volume. With an emphasis on patient centered innovations and strong technical expertise, BD Medical - Pharmaceutical Systems partners with pharmaceutical and biotechnology companies to help them achieve their goals. We support product launch and life cycle management through a comprehensive set of services and solutions from development to launch that help to de-risk the combination product development process.

EdgeOne Medical is a device development professional service organization serving the bio-pharmaceutical industry with end-to-end offerings to navigate the development and commercialization pathway of combination products.  Backed by seasoned industry experts and a deeply collaborative, client-first mindset, EdgeOne Medical has a track record of supporting over 135 clients across a full range of device modalities including pre-filled syringes, auto- & pen injectors, inhalers, on body injectors, vial access devices, custom device delivery systems, complex systems, digital apps, connected devices and innovative medical device technologies. EdgeOne Medical stands as the only true Integrated Device Partner for Combination Products, with a cross-functional device team complemented by in-house, FDA inspected device testing labs operated by experienced device engineers to help clients deliver safe, effective, and patient-centric solutions.  Founded in 2012, EdgeOne Medical is headquartered in Wheeling, IL.

Halozyme’s ENHANZE® drug delivery technology is based on our patented recombinant human hyaluronidase PH20 enzyme, rHuPH20, which locally degrades hyaluronan (HA) in the subcutaneous (SC) space. This allows for increased dispersion and absorption of co-administered therapies. ENHANZE technology degrades the HA around the injection site allowing large volumes (up to 300-600 mL) to be delivered in a single subcutaneous injection. Large volume injections may allow some biologics and small-molecule drugs that are administered intravenously to be delivered subcutaneously potentially providing an improved patient experience by decreasing infusion times or reducing the need for multiple injections. For more information, visit: https://halozyme.com/

Phillips Medisize stands as a trusted partner for the world’s top pharmaceutical companies, guiding them from discovery through delivery in the creation of advanced drug delivery devices. With over 60 years of CDMO expertise, the company specializes in designing, developing, and manufacturing patient-focused devices for parenteral, inhalation, and ocular applications.

The acquisition of Vectura in 2025 further broadened Phillips Medisize’s capabilities to include inhaled drug development for both small molecules and biologics, supporting products such as, nebulizers, DPIs and nasal inhalers. Leveraging extensive industry knowledge, Phillips Medisize develops effective strategies for every stage of product development, from initial clinical trials to full-scale commercial production. Additionally, their customizable platform products are designed to speed up development timelines, mitigate risks, and optimize cost efficiency.

With a commitment to quality and innovation, Phillips Medisize ensures drug delivery devices are engineered for reliability and patient needs.

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Driven by our purpose of “enabling patients’ independence”, we partner with leading pharma and biotech companies to develop self-injection systems and digital solutions that enhance patients’ treatment experience and quality of life. Our customers benefit from our proven track record and scalable, global manufacturing excellence, with locations across three continents and headquarters in Switzerland. By focusing on innovation, we challenge the status quo and shape the future of state-of-the-art drug delivery. We cover the entire drug delivery value chain, providing peace of mind through our end-to-end services, from design, development, to final assembly, labeling, and packaging.

Amneal Pharmaceuticals (NYSE: AMRX), headquartered in New Jersey, with annual revenue of about $2.2 billion develops, manufactures, commercializes, and distributes a diverse portfolio of essential medicines, including complex generics, injectables, biosimilars, and specialty branded pharmaceuticals. Amneal utilizes its novel gastric oral drug delivery technologies for improving specialty drug performance.To learn more, please visit www.amneal.com

Crux was founded to address challenging technical briefs and deliver compelling solutions for the drug delivery and medical device sectors. Based in Bristol, United Kingdom and Boston, Massachusetts , our technical team champion evidence-based problem solving, coupling world-class equipment, software and facilities with a scientific approach to maximise success. Be it discovering unmet user needs, developing novel products or deploying new technologies, our team are dedicated to solving our client’s biggest problems. To learn more, visit www.cruxproductdesign.com

EdgeOne Medical is the Contract Development Organization that specializes in supporting device development and testing programs for combination products for 10 of the top 20 global pharma and the companies they acquire. Utilizing their proprietary EdgeOne Labs and their proven Edgineering method, EdgeOne Medical is considered to be the most technically advanced and reliable partner for ensuring device programs overcome challenges, get on the market and stay on the market. To learn more, please visit www.edgeonemedical.com

Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable’s body-worn enFuse® delivers high-volume (5-25 mL) pharmaceutical and biologic therapeutics via subcutaneous administration, with the aim of improving convenience, supporting superior outcomes, and advancing healthcare system economics. For more information, please visit www.enableinjections.com.

KORU designs and manufactures easy-to-use infusion systems for large volume therapies (10+ ml). Our proven, preferred Freedom Infusion Systems consist of two syringe driver options to accommodate a variety of syringes, tubing and subQ needles. Let us assist with the planning and execution of your large volume subcutaneous drug delivery! To learn more, please visit www.korumedical.com

Our purpose is to solve the toughest problems in life science by collaborating with the global scientific community – and through that, we aim to accelerate access to better health for people everywhere. We provide scientists and engineers with best-in-class lab materials, technologies, and services. With the 2015 combination of EMD Millipore and Sigma-Aldrich, we now have a broad portfolio of 300,000 products, an expanded global footprint, and an industry-leading eCommerce platform. To learn more, visit https://www.emdmillipore.com/US/en

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise in complex oral formulations. Our specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. To learn more, please visit www.adarepharmasolutions.com

For pharma customers worldwide, Aptar Pharma is the go-to drug delivery expert, from formulation to patient, providing innovative drug delivery systems, components and active material solutions across the widest range of delivery routes. Aptar Digital Health solutions help improve the patient treatment experience and Aptar Pharma Services help accelerate and derisk the drug development journey. To learn more, visit www.aptar.com/pharmaceutical

Bionaut is a micro-robotic CNS drug delivery platform. Conventional CNS drug delivery methods (infusion, intra-thecal) grapple with the blood-brain barrier, yielding low brain concentration, limited efficacy, and systemic side effects. Bionaut is backed by $76M+ in funding from top investors including Khosla, Gates Ventures, Mayo Clinic Ventures, UC Healthcare Ventures and Altitude Ventures, among others. We have two in-house clinical programs and are gearing up for our first clinical program at Mayo Clinic later this year. Bionaut is actively seeking pharma collaborations and licensing opportunities. For more information, visit https://bionautlabs.com/

Expand your design possibilities with Celanese engineered materials and support from in-house technical experts. Our high-performance polymers and thermoplastics unlock opportunities for improving patient care with cutting-edge medical and pharmaceutical solutions. Applications include drug delivery, long-acting controlled release delivery, medical devices, orthopedics, advanced surgical instruments, connected devices and more. To learn more, visit http://www.celanese.com/

Our purpose is to optimize the potential of injectable drugs that have emerging and hard-to-address delivery needs. We do this by designing, developing and supplying innovative, flexible drug delivery device platforms. Our growing portfolio addresses compelling problems, including microliter dosing, viscous drug delivery, multi-dosing, variable dosing and minimizing drug waste. To learn more, please visit www.congruencemed.com

Credence MedSystems is an innovator in injectable drug delivery devices, offering our pharma partners a simplified path to commercialization of a best-in-class delivery system. The Companion Safety Syringe System was born from Credence’s philosophy of Innovation Without Change, allowing our customers to impress and protect their end users while preserving their existing processes, sourcing strategies and preferred primary package components. The Companion is available in luer needle, staked needle and dual chamber reconstitution configurations. Across the platform, the user performs the injection, receives end-of-dose cues and then the needle automatically retracts into the syringe, preventing reuse. To learn more, visit us at www.credencemed.com.

Crux was founded to address challenging technical briefs and deliver compelling solutions for the drug delivery and medical device sectors. Based in Bristol, United Kingdom, our technical team champion evidence-based problem solving, coupling world-class equipment, software and facilities with a scientific approach to maximise success. Be it discovering unmet user needs, developing novel products or deploying new technologies, our team are dedicated to solving our client’s biggest problems. To learn more, visit www.cruxproductdesign.com

Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company headquartered in Canada, with offices in the USA and UK. Entos leverages its proprietary Fusogenix™ platform in its own drug development programs and multiple licenses with pharmaceutical companies. Most recently, Entos partnered with Lilly to develop CNS and PNS-targeted genetic therapies. Learn more at www.entospharma.com

EXACT Therapeutics is a clinical stage biotech company with a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT is a unique approach to ultrasound-mediated, targeted delivery of advanced therapeutics, with the potential to significantly amplify therapeutic delivery across a multitude of indications including oncology and neurological conditions For more information, visit https://exact-tx.com/

Flex is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets. Flex’s health solutions business focuses on medical device and drug delivery design, development and manufacturing solutions for pharmaceutical and medtech companies, including extensive work in injection pens, autoinjectors, wearable pumps and smart inhalers. Our approach is supported by FDA-registered and ISO 13485 compliant and ISO 11608-1 accredited facilities, with a world-class single quality system across sites. For more information, visit www.flex.com

InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company specialized in the development of complex parenteral sustained release formulations. By using our proprietary biodegradable polymers we can make microspheres, erodible gels and solid implants resulting in long acting and minimally invasive drug delivery products of small, medium sized (peptides) and large (proteins, antibodies) drug molecules. Learn more at www.innocorepharma.com.

Insightec is a global healthcare company dedicated to unlocking the mysteries of the brain and transforming the lives of people with neurological disorders by using incisionless focused ultrasound, enabling them to regain their sense of self and realize the possibilities of tomorrow, today. To learn more, visit https://insightec.com/

Kaléo is dedicated to creating innovative healthcare solutions that help protect and empower patients. Our auto-injection technologies are protected by an extensive intellectual property portfolio of patents and meet the FDA draft guidance standard for 99.999% device reliability. Kaléo is privately-held and headquartered in Richmond, VA. Visit www.kaleo.com

KeborMed delivers the industry’s most advanced, regulatory compliant connectivity platform for MedTech and Pharma applications. Our plug-n-play solution transforms data management, bypassing traditional custom development hurdles. This empowers businesses to expedite high-quality drug discovery and delivery, significantly enhancing patient care and providing a competitive edge in the rapidly evolving healthcare landscape. To learn more, please visit https://kebormed.com/

Nothing is easy when it comes to developing and manufacturing drug delivery systems. But our extensive knowledge, steadfast spirit, and inventive character mean we have navigated endless challenges to bring a wealth of firsts, innovations, and successes to pharmaceutical and biotech drug-delivery initiatives. Kindeva’s MTS platform provides elegant microneedle-based delivery devices, refined and suited to our partners’ programs. From early-phase feasibility to final design requirements, we can meet the needs of challenging drug formulations. Refined over several device generations, Kindeva’s microstructured systems are designed for consistent intradermal delivery of vaccines and biologics. Our patient-friendly technology is available in two formats, providing an option of delivery routes to enable your commercial success. With sophisticated project management, rigorous quality processes, manufacturing excellence, and cGMP facilities, Kindeva supports a reliable supply chain for your program. For more information, visit https://kindevadd.com/

Kymanox is a life science professional services organization that offers engineering, scientific, compliance, and project management support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. Kymanox helps clients navigate commercialization challenges that arise throughout a product’s life cycle. To learn more, visit www.kymanox.com.

MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment. The BEPO® technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for several days, weeks or months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. Based in Montpellier, MedinCell currently employs more than 155 people representing over 30 different nationalities. For more information, visit https://www.medincell.com/

OxSonics is a pioneering clinical-stage company on a mission to transform cancer treatment with its breakthrough SonoTran® technology, utilising Innovative proprietary sonosensitive particles, co-administered with anti-cancer drugs, and “activated” by a novel ultrasound device. This enhances the delivery of oncology drugs into solid tumours, improving efficacy and/or reducing off-target toxicity. To learn more please visit: https://oxsonics.com/

OxSonics is a pioneering clinical-stage company on a mission to transform cancer treatment with its breakthrough SonoTran® technology, utilising Innovative proprietary sonosensitive particles, co-administered with anti-cancer drugs, and “activated” by a novel ultrasound device. This enhances the delivery of oncology drugs into solid tumours, improving efficacy and/or reducing off-target toxicity. To learn more please visit: https://oxsonics.com/

We believe in the power of ingenuity to build a positive human future. As strategies, technologies, and innovation collide, we create opportunity from complexity. Our diverse teams of experts combine innovative thinking and breakthrough technologies to progress further, faster. Our clients adapt and transform, and together we achieve enduring results. We are more than 4,000 specialists – strategists, innovators, designers, consultants, digital experts, scientists, engineers and technologists, with over 45 years’ experience in the design, development, characterisation and evaluation of drug delivery devices. PA Consulting has dedicated inhaled and parenteral drug delivery teams, covering both conventional and smart connected devices. Services include complete device design and development, human factors studies, device identification, selection and customisation, device strategy, product characterisation, combination product project support, development of custom test equipment, design verification programmes, manufacturing process innovation and transfer to manufacturing. Our teams operate globally from offices across the UK, Ireland, US, Nordics, and Netherlands. To learn more please visit: www.paconsulting.com/industries/life-sciences/pharma-and-biotech

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more information, visit www.pfizer.com

Since 2003, PharmaCircle has been providing in-depth pharma intelligence, formulation and drug delivery analysis, and supply chain insights to the life sciences industry. PharmaCircle will be showcasing some of our intelligence solutions at PODD 2025, including:

- Partnership Explorer evaluates unpartnered pharma innovation opportunities and potential strategic partners from around the world.

- Formulation Plus provides data-rich insights into critical formulation parameters, including tables detailing maximum excipient amounts per admin and per day by route of administration, and excipient amounts in percent across all dosage forms and delivery technologies with links to comprehensive excipient records.

- Drug Delivery Technology Reviews – 17 research reports, each updated annually and providing a detailed assessment of the technology space and comparative analysis of legacy and next generation drug delivery technologies/devices. Pipeline Dynamics analyzes the global drug, biologics and vaccine development landscape, charting 10+ years of pharmaceutical pipeline trends and tracking when programs moved to clinic.

PharmaCircle curates vast amounts of pharma and device industry data into due diligence level intelligence that is comprehensive and reliable, and provides concierge-level support to help our clients fully leverage the value of this information.

For more information, visit our booth at PODD or www.pharmacircle.com.

Pharma Latch is developing a series of healthcare professional and self-administered intradermal injection devices based on an innovative angled needle platform technology. We are funded through venture capital, and more recently by West Pharmaceutical Services. Our first product, the Pharma Latch Hollow (PLH), is currently under development as a sterile-packed, single-use medical device (Class II, FDA 510(k) pathway) and is in late-stage manufacturing in the USA. The PLH is ready for use in pre-clinical studies now (in small or large animals) with clinical evaluation planned for 2025. A series of self-injector devices, composed of the same core platform technology are also under development. For more information, visit https://www.pharmalatch.com/

Portal Instruments is a MedTech company pioneering next-generation drug delivery technologies. Spun out of MIT, Portal is developing a cost-effective, reusable injection platform for biologics, including GLP-1s. The NEXUS smart auto-injector is fully reusable, automates the injection process, and delivers a best-in-class user experience. It also features seamless connectivity through an AI-driven app that supports patients and engages stakeholders throughout the treatment journey. For pharmaceutical partners, NEXUS offers a highly cost-effective and rapid deployment model. The device never comes into contact with the drug, eliminating the need for reformulation or repackaging. All personalization and therapeutic adaptability are managed through software, enabling rapid iteration and customization without changes to the physical device.

PSN Labs is your full-service partner for engineering and product development, specializing in drug delivery solutions. From concept to commercialization, we manage every step, ensuring risk mitigation and optimization through virtual and physical processes. Our ISO 17025 Testing Lab offers biocompatibility testing, drug stability assessments, and regulatory consulting. With ISO 13485-certified molding facilities equipped with cleanroom capabilities, we streamline manufacturing and functional prototyping. Consolidating services with PSN Labs saves time, costs, and ensures the highest quality standards are met, providing a hassle-free experience for our clients. For more information, visit https://www.psnlabs.com/

ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. ReCode’s SORT LNPs are engineered with a biochemically distinct fifth lipid to help the body “sort” and direct the LNPs to other targeted organs such as the lung and spleen with the ability to bypass the liver, if desired. For more information, visit www.recodetx.com and follow us on Twitter @ReCodeTx and LinkedIn.

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Sanofi’s mRNA Center of Excellence (CoE) pursues the development of new mRNA vaccine candidates to address the long-standing challenges in cancer, immune-mediated diseases, and rare diseases, focusing on thermostability and tolerability. For more information, visit www.sanofi.com

Founded in 2016 and headquartered in Maryland, U.S., Theradaptive is a venture-backed, clinical-stage biopharmaceutical and medical device company. The company aims to leverage its therapeutic delivery platform to precisely deliver biologics to targeted areas of the body with high local precision, persistence, and potency, addressing significant medical needs. Theradaptive’s protein engineering platform allows therapeutic molecules to be "painted" onto implants, ensuring localized and sustained therapy without systemic side effects. The novel technology supports the development of new therapies in spine, orthopedics, soft tissue repair, and targeted immuno-oncology. Theradaptive's spinal fusion product, OsteoAdapt SP, recently secured IDE Approval from the FDA to begin clinical trials, opening a new chapter in Theradaptive's growth as a clinical-stage company. To learn more, please visit https://www.theradaptive.com/.

Windgap Medical is imagining the future of reconstitution devices. Our autoinjector platforms simplify, automate, and speed up the delivery of difficult-to-mix drugs, freeing patients, families, and potential cures from the limitations of current medical delivery technology. We are a proud industry leader in self-administration devices that consider the needs of patients first when delivering complex injectables. To learn more, visit https://windgapmedical.com/

Ypsomed is the leading developer and manufacturer of injection systems for the self-administration of liquid injectable medications. As the reliable partner of pharmaceutical and biotech companies for more than 40 years, Ypsomed provides tailored selfcare solutions to meet specific needs. Backed by a proven track record, Ypsomed offers the most comprehensive and innovative platform portfolio for pens, autoinjectors, and on-body devices. Delivered with best-in-class execution and ready to integrate with digital health services, these solutions help simplify therapy and improve the quality of life for millions of people living with chronic conditions. Ypsomed is headquartered in Burgdorf, Switzerland, and operates a global network of manufacturing facilities. More than 2,000 employees worldwide are committed every day to making selfcare simpler and easier.

Altaviz is the global leader in designing gas-powered delivery systems. Learn how to harness gas-power for delivery of High Viscosity / High-Volume biologics and challenging drug delivery applications with the AltaVISC High Viscosity / High-Volume Auto-Injector; one of a portfolio of Altaviz gas-powered drug / implant delivery technologies. To learn more, please visit www.altaviz.com

ApiJect™ is a global medical technology company whose products are designed to provide the advantages of prefilled syringes (quality, convenience, safety) at the cost- efficiency of multi-dose formats, regardless of manufacturing volume. Our Platform achieves this by bringing together two trusted manufacturing technologies: Blow-Fill- Seal aseptic filling and high precision injection molding. To learn more, please visit www.apiject.com

Ascendia Pharmaceutical Solutions is a specialty CDMO that provides custom formulation development, analytical support, and GMP manufacturing for both small molecule and biologic drug products. Our experts deliver sophisticated formulations to enhance bioavailability, solubility and stability, while reducing toxicity using GRAS (Generally Recognized As Safe) materials and four proprietary nanotechnology platforms – NanoSol®, EmulSol®, AmorSol® and LipidSol®. Ascendia offers its aseptic and non-aseptic manufacturing services to biotech and pharmaceutical companies who seek a CDMO partner that is steeped in Socratic process for their formulations. As candidates advance from preclinical and early clinical development to late-stage clinical trials and beyond, Ascendia provides efficient scale-up for oral, injectable and transmucosal/ophthalmic programs. For more information, visit AscendiaCDMO.com.

Battelle is a unique, non-profit, service-oriented organization dedicated to solving the world’s challenges for the betterment of humankind. Within the field of drug delivery, we leverage our extensive experience in the design, engineering, and commercialization of drug delivery devices with specialized knowledge in materials, formulation, pre-clinical research, and user research to create solutions preferred by all stakeholders (clinicians, patients, and project sponsors). Connect with us to learn more about our 95-year heritage of innovative products and discuss what new challenges we can take on together. Learn more at www.battelle.org/health

Bionaut: Revolutionizing drug delivery to the brain. Bionaut is a global biotechnology and drug delivery company dedicated to pioneering innovative solutions for brain-targeted therapies. Our cutting-edge precision drug delivery platform enables the accurate, safe, and effective administration of treatments to challenging brain regions for a diverse range of therapeutics. Backed by robust pre-clinical safety data and poised for upcoming 2024 clinical trials, Bionaut is seeking partnerships with forward-thinking pharmaceutical industry pioneers to join our mission. Together, we can unravel the complexities of localized brain conditions and transform neurological care. Join us at the conference and learn more about our mission at www.bionautlabs.com 

Focusing on optimizing drug performance through delivery, Celanese has a patented drug delivery platform, VitalDose® , that addresses a variety of formulation challenges to achieve the desired release profile for your drug. The VitalDose® technology is focused on providing innovative, long-acting solutions for localized and systemic delivery for the minimization of interventions, reduction of adverse effects, and optimization of efficacy. 

The platform has been approved for use in numerous pharmaceutical and medical device applications and Celanese works closely with partners to create innovative, sustained-release implant therapeutics for the continuous delivery of a wide range of drug types.  While we have a long history of success with small molecule drugs, our current focus is on enabling the delivery of complex biologics, RNA, and peptides for months to years of therapy.  We are actively supporting marketed products and development programs in Oncology, Ophthalmology, CNS disorders, Women’s Health, Cardiovascular Diseases, Rare Diseases, Endocrinology, Infectious Diseases and Osteoporosis.  To learn more about our drug delivery applications, visit www.vitaldose.com

In addition, Celanese has a wide range of high-performance polymers and thermoplastics ideal for innovative medical devices, orthopedics, advanced surgical instruments, connected devices and more.  To learn more about polymers for medical devices, visit http://www.celanese.com/applications.

Clexio Biosciences is a CNS-first clinical-stage pharmaceutical company with a broad pipeline. Clexio is dedicated to developing novel therapies for patients suffering from serious neurological and psychiatric conditions. One of our proprietary technologies is OLAR® (Oral Long Acting Release) platform to enable continuous drug delivery to the GI tract. To learn more, please visit www.clexio.com

Comera Life Sciences, Inc. is a preclinical stage biotech company developing a portfolio of proprietary antibodies that incorporate its proprietary formulation platform, SQore. The SQore platform converts intravenous (IV) biologics to subcutaneous (SQ) versions. We collaborate with partners interested in accessing our platform to convert biologics into out-patient delivered subcutaneous injections. Visit www.ComeraLifeSciences.com.

Congruence Medical Solutions is a US-based drug delivery device company engaged in the design, development and supply of innovative drug delivery devices addressing unmet, emerging and hard-to-solve problems in a) microliter dosing, b) injection of viscous formulations and c) minimizing drug waste at the point of injection.

Corbion Biomaterials is a leading supplier of GMP-grade bioresorbable polymers designed specifically for drug delivery applications, including long-acting injectables (LAIs). Our PURASORB® portfolio offers a proven and versatile platform, with tunable properties that support the controlled release of APIs over defined timeframes, from weeks to years. We offer both off-the-shelf and custom polymer solutions, enabling precise alignment with your target product profile and streamlined development from design to scale-up. Learn more at www.corbion.com.

DIANT Pharma provides award-winning continuous processing technology and services, applicable for nanoparticle drug products and vaccines. Our process is based on an end-to-end adaptable, high-throughput and fully automated system that reduces the number of batches, processing steps, and facility size requirements by 70-90%. Learn more at www.diantpharma.com.

As innovators in nutrition, health, and beauty, we reinvent, manufacture, and combine vital nutrients, flavors, and fragrances for the world’s growing population to thrive. 

In the Biomedical division, we serve as a committed partner in driving sustainable innovation in healthcare, from spark to solution. Our biomaterial products, customized solutions and expert services are recognized for their unmatched quality, reliability, and performance worldwide. 

Together, we bring progress to life every day, everywhere, for billions of people. To learn more, visit dsm-firmenich.com/biomedical

Elcam Drug Delivery Devices (E3D™) is a subsidiary of Elcam Medical™, an Israel-based group with 40 years of experience in the development, manufacturing and global distribution of medical devices. E3D is focused on the design, development, manufacturing and supply of injectable drug delivery devices for self-administration and use in non-clinical environments. Its broad technology portfolio encompasses devices suitable for drugs in a range of primary containers – including auto-injectors, on-body delivery systems, and smart devices with wireless connectivity.

Based on more than 10 years of research, EVEON designs and develops custom devices for drug preparation and delivery dedicated to innovative therapeutics. We provide solutions to improve patient compliance and therapeutic performance. Learn more about us at, https://eveon.eu/en/

Evonik Industries, a global leader in specialty chemicals, provides drug delivery technologies, API manufacturing, intermediates, ingredients for nutraceuticals, amino acids and derivatives. Drug delivery technologies include modified release formulation development services, solubility enhancement, functional excipients, bioresorbable polymers, lipid nanoparticle mRNA delivery, and GMP manufacturing for oral and parenteral formulations. Advanced delivery technologies for extended-release parenterals are offered for small molecules, peptides, proteins, antibodies, and nucleic acids. Learn more about us at www.evonik.com/healthcare.

H&T PHopewell Therapeutics is discovering and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. Leveraging its robust IP portfolio and expansive ionizable lipid library, Hopewell is developing an internal pipeline targeting lung diseases while pursuing partnerships in oncology, infectious diseases, rare genetic diseases, and neurology. To learn more visit www.hopewell-tx.com

Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Our team of world experts in neutrophil biology and nanoparticle development are using cutting edge tools to bring new therapies to patients across a broad spectrum of diseases. For more info please visit www.immunyx.com

InnoCore Pharmaceuticals is a biopharmaceutical formulation company specialized in the development of complex parenteral sustained release formulations. By using our proprietary biodegradable polymers we can make microspheres, erodible gels and solid implants resulting in long acting and minimally invasive drug delivery products of small, medium sized (peptides) and large (proteins, antibodies) drug molecules. Learn more at www.innocorepharma.com.

We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS LOHMANN Therapie-Systeme AG. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) as well as wearable drug delivery devices (“OBDS”). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS’s innovation pipeline contains both partner-funded and proprietary, LTS-funded projects. With its SorrelTM wearable drug delivery platform LTS offers patient friendly solutions for complex drugs delivery at home. To learn more, please visit www.ltslohmann.com

Lubrizol Life Science Health (LLS Health) is a leading pharmaceutical CDMO and excipient supplier. Staffed by industry experts, we offer R&D formulation and clinical/commercial drug product manufacturing supported by analytical testing, ICH stability programs, and HPAPI/controlled substance handling. Our technology-agnostic team has expertise in solubility/bioavailability enhancement, sterile/aseptic manufacturing, and long-acting injectables/implantables. For more information visit: www.lubrizolcdmo.com

Mott is a technology-driven, precision filtration company trusted by the world’s best technical and performance brands across four core markets: Medicine, Computing Power, Clean Energy, and Space Exploration. Mott’s products can be found in everything from lifesaving medical devices to artificial intelligence to the Mars Rover. To learn more, visit https://mottcorp.com/

PharmaShell® is Nanexa’s novel drug delivery system. PharmaShell® achieves a high drug load, low injection volume, with excellent in-situ stability, controlled burst release and depot length. This is achieved by formulating a suspension containing coated drug particles with a controlled solubility of the coating. As the coating dissolves, the drug is released in a pre-defined manner over time. To learn more, visit https://nanexa.com/

Nanomol Technologies offers tailored nanomedicine development and manufacturing solutions by our patent protected, green and robust DELOS technology, in addition to advanced GMP particle characterization services. DELOS nanocarriers stabilize, protect and improve the performance of APIs -from small chemical molecules to biologics, including peptides, proteins and nucleic acids, enabling new administration routes and enhanced or novel drug products.

For more information, visit https://nanomol-tech.com/

NanoViricides, Inc. is a clinical stage company creating novel nanomaterials called “nanoviricides™” to cure viral infections. Oral NV-387 is in Phase 1a/1b for COVID and also has demonstrated broad-spectrum activity against multiple other viruses including RSV. Our safe nanomaterials can be receptor-targeted to deliver API cargo to specific cells. Our own multi-Kg-scale cGMP-compliant manufacturing facility has capabilities for making API and Drug Products (formulation, fill, finish, label, packaging). To learn more visit www.nanoviricides.com

Nissha Medical Technologies - Isometric is a vertically integrated provider of micro molding and automated assembly solutions, with a focus on high-precision applications in the medical device and drug delivery sectors. Vertical integration enables comprehensive control over precision (controlling microns), cost and speed. 

Our expertise provides solutions tailored to various drug delivery devices. We are able to mold thin-walled components—including needle tips and cannulas—using advanced, challenging materials. This capability not only addresses the technical demands of modern drug delivery but also supports efficient production at scale, facilitating precise and reliable therapeutic delivery.

Nissha Medical Technologies is a global CDMO offering design, development and manufacturing solutions for complex single use minimally invasive surgical devices, clinical wearables and clinical accessories.

NOF CORPORATION is the leading commercial supplier of drug delivery products such as activated PEGs, lipids and ultrapure Polysorbates 80. Our cutting edge products include Pendant type single molecule PEG linkers for ADCs and SS-lipids for nucleic acid and gene delivery. For more information, visit www.nofamerica.com

NovaXS Biotech is a smart medical device startup developing the next generation of smart needle-free drug delivery platform that simplifies the drug self-administration process, improves the medication adherence and optimizes the remote treatment outcomes.To learn more visit www.novaxs.co

Oakwood Labs specializes in the development and aseptic manufacturing of sustained-release microsphere products, ranging in duration from weeks to one year, through the use of our patented Chroniject™ technology. Oakwood’s FDA approved cGMP aseptic facility enables partners the ability to bring products from feasibility concepts to successful commercialization. To learn more, visit https://oakwoodlabs.com/

Pharmacin is a global biotechnology company with a proprietary formulation technology, SpraySol™. This IP protected technology is a scalable, multicomponent amorphous solid dispersion formulation combined with spray drying. The technology, successfully advanced in the clinic, can be applied to early phase NCE’s and 505(b)(2) candidates. To learn more visit www.pharmacin.com

We are a leader in next-generation vaccine and biologics delivery technology. With one core platform, we have multiple drug delivery devices for HCP and self-administration. Pharma Latch Hollow is an innovative solution that utilises hollow microneedles for direct intradermal administration delivered by HCP’s. The technology creates a new injection usability paradigm that is highly cost effective and scalable. For more information visit: www.pharmalatch.com

Pirouette makes injections as easy as pushing a button, the key to more effective treatment, improved patient outcomes, and to deliver more efficient, lower cost care. The enhanced patient experience, from procurement through end-use, magnifies the value of the delivered drug products for stakeholders – patients, providers, payers, and pharmacists. To learn more, visit: pirouettemedical.com

Re-Vana Therapeutics is a Transformative Ocular Therapeutics company, developing Sustained Release 6 Months+ Biologics with our proprietary biodegradable photo crosslinked technologies. To learn more, please visit https://www.revanatx.com/

Remedium is a gene therapy company developing treatments for large unmet clinical needs. Our ‘Prometheus’ platform enables delivery of virtually any subcutaneously administered protein as a single injection, adjustable-dose gene therapy. Prometheus delivers large, non-integrating constructs with high durability, enabling low-cost replacement of a breadth of subcutaneous protein injection therapies. To learn more, visit https://www.remedium-bio.com/

Renishaw Neuro Solutions enables direct-to-target delivery for a broad range of applications. Using the neuroinfuse™ drug delivery system, predictable and translatable therapy infusions in R&D and clinical trials can become a reality. Our Lab2Clinic™ service supports pharma through the R&D journey, translating into clinical trials and scaled-up commercialisation. To learn more, visit https://.renishaw.com

The Sanner Group is a global Contract Development and Manufacturing Organization (CDMO), dedicated to delivering high-quality, finished drug delivery devices for its customers. With over 750 employees and cutting-edge manufacturing facilities across the EU, US, and China, Sanner Group excels in turning complex medical device projects into reality. Their expertise extends across a wide range of critical drug delivery systems, such as autoinjectors, infusion pumps, inhalers, safety syringes, and connected devices. The company's innovative approach to device design and development is further strengthened by its Design Centres of Excellence in the US (Gilero) and UK (Springboard), which drive cutting-edge solutions for customers. For more information, visit https://www.sanner-group.com/

Secant Group’s innovative and patent-protected Hydralese® polymer platform provides an elastomeric and bioresorbable polymer that enables long-acting drug delivery. Secant’s material experts specialize in developing custom finished dosage forms for the delivery of a  variety of API’s. We have the expertise to support pharmaceutical payload delivery development to enable novel, patient-centric therapies that positively impact health. Learn more at secant.com/drug-delivery

Senda applies deep molecular profiling and advanced analytics to natural nanoparticles and information molecules, like mRNA. By combining our knowledge from both, we can program both within and to the cell. To learn more, visit https://www.sendabiosciences.com/

SeraNovo, a Netherlands-based oral formulation company, specializes in enhancing the bioavailability of water-insoluble small molecules. Leveraging our proprietary eutectic formulation platforms and efficient one-step manufacturing process, we significantly reduce drug development timelines and expedite access to the clinic. To learn more, please visit www.seranovo.com

SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and wearable drug delivery systems. We offer final assembly, labeling, and packaging solutions for our drug delivery devices, and also provide contract manufacturing and engineering services for the production of complex medtech and industrial products. With locations in Switzerland, Taiwan, Sweden, and the US, our experienced designers and engineers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investments in R&D have enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high-volume and high-viscosity formulations and can be enhanced through digital implementations. To learn more, visit www.shl-medical.com

SiCare Bio is enabling the next generation of nano-therapeutics through its novel drug delivery platform. Underpinning SiCare’s platform is its precision nanoporous silicon dioxide particles which are customized for specific molecules and release profiles. SiCare is working with industry partners on both long acting injectables and intracellular release applications.

Named the 2022 Top Emerging Company at BIO International, SiVEC Biotechnologies has developed BactPac™, a drug delivery platform to enable the next generation of nucleic acid and gene therapies. BactPac overcomes the limitations of viral and nonviral delivery systems and is a complete solution for all-in-one therapeutic payload production and targeted delivery. Visit us at www.sivecbiotechnologies.com

SMC Ltd. provides “end-to-end” integrated services for clinical and commercial manufacturing of drug delivery combination products, and specializes in the development of patient-centric autoinjectors for challenging drug formulations including high viscosity/high volumes. Visit us at www.smcltd.com.

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. For more information, visit www.stevanatogroup.com

Surf Bio is a preclinical biopharmaceutical company transforming the delivery of antibodies and biologics.

Powered by a proprietary polymer platform, our SnapShot™ technology enables ultra-high concentration formulations (up to 600 mg/mL) and subcutaneous delivery of doses up to 1,000 mg via standard autoinjectors, with no reconstitution, device redesign, or specialized manufacturing. SnapShot formulations support longer dosing intervals, at-home administration, and a dramatically improved patient experience.

To learn more, visit https://www.surf.bio

SynerGene seeks to improve patient outcomes through novel nanomedicines that enhance the delivery of therapeutic molecules via a nanocomplex that not only “homes” to cancer cells but also delivers diverse payloads across the blood-brain barrier. SynerGene’s SGT-53 is now in a Phase II trial for patients with advanced pancreatic cancers. For more information visit synergeneapi.com

Team Consulting is a world-class partner in medical device design and development. Working with leading pharma companies to innovative start-ups, we apply the latest approaches in design theory, engineering ingenuity and human factors to create user-centered solutions for your drug delivery needs. For more information visit https://www.team-consulting.com/

Theradaptive’s protein engineering platform allows therapeutic molecules to be “painted” onto implants delivering localized, sustained therapy where it is needed the most, eliminating detrimental side effects from systemic delivery. Our therapies address the spinal fusion, dental defect, and oncology markets, giving patients who have no good options a better choice. To learn more, please visit https://www.theradaptive.com/

Triastek, Inc. is a global healthcare company, developing medicines with proprietary, pioneering 3D printing technology called Melt-Extrusion Deposition (MED®). Triastek is dedicated to revolutionizing the delivery, development and manufacturing of pharmaceutical products by unlocking the next generation of medicine through the use of 3D printing technology. To learn more visit https://www.triastek.com/

TTP is a product development consultancy that has been helping pharma and medical device companies develop new, innovative and marketable drug delivery solutions for over 30 years. This experience encompasses a broad range of respiratory, parenteral and transdermal devices. To learn more, visit https://www.ttp.com/

Xeris, headquartered in Chicago, is a commercial stage biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products utilizing its proprietary ultra-concentrated (>400mg/mL), ready-to-use, injectable formulation platforms XeriSol ™ and XeriJect™. Xeris has established multiple XeriJect™ partnerships for biologics and actively seeks to license its formulation platforms.” Learn more at https://www.xerispharma.com/research-development/technology

Ypsomed is the leading developer and manufacturer of injection systems for the self-administration of liquid injectable medications. As the reliable partner of pharmaceutical and biotech companies for more than 40 years, Ypsomed provides tailored selfcare solutions to meet specific needs. Backed by a proven track record, Ypsomed offers the most comprehensive and innovative platform portfolio for pens, autoinjectors, and on-body devices. Delivered with best-in-class execution and ready to integrate with digital health services, these solutions help simplify therapy and improve the quality of life for millions of people living with chronic conditions. Ypsomed is headquartered in Burgdorf, Switzerland, and operates a global network of manufacturing facilities. More than 2,000 employees worldwide are committed every day to making selfcare simpler and easier.

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years’ industry experience, Catalent has proven expertise in bringing more customers’ products to market faster, enhancing product performance, and ensuring reliable clinical and commercial product supply. To learn more, visit https://www.catalent.com/

3P innovation is a UK-based custom automation company supporting pharma and medical device businesses to develop new products, devices and novel production processes. 3P innovation specialises in aseptic processing and powder/liquid filling technologies, designing and building scalable GMP production solutions, from lab-scale/bench-top machines through to commercial-scale lines. To learn more, please visit www.3pinnovation.com

AdhereTech is revolutionizing clinical trial adherence with its innovative Aidia System. Unlike traditional methods such as pill counting, journals, or video capture, our patented smart cap technology provides unparalleled accuracy in medication adherence tracking while minimizing patient burden. We address the critical need for increasing medication adherence, helping biotech and pharma companies maximize effect size and demonstrate efficacy. Our solution overcomes limitations of current offerings and doesn’t require additional stability testing. By partnering with AdhereTech, clinical operations teams ensure regulatory compliance, optimize drug accountability, and can avoid significant financial and operational consequences of failed trials due to non-adherence. For more information, please visit https://adheretech.com/

Most pharma companies focus on drugs, not devices. At Archimedic, we provide drug delivery expertise and an ISO 13485 certified QMS to help pharma companies design user focused devices, rapidly gain regulatory clearance, efficiently scale manufacturing, and successfully commercialize combination products.

To learn more, please visit https://www.archimedic.com/

Ardena is a fully integrated CDMO with a core focus on bringing molecules to the clinics. Our services include: Small-molecule API projects, spanning route scouting, development, and accelerated manufacturing, including HPAPI; Phase-appropriate drug product development and manufacturing, bioavailability enhancement expertise and HPAPI and controlled substances capabilities; Packaging and logistics for clinical trials; Expert CMC regulatory support; Leading nanomedicine development and manufacturing services; Comprehensive bioanalytical expertise. To learn more, please visit https://ardena.com/

In addition to developing demonstration devices and training materials that go beyond just informing to truly educating, Artcraft Health has launched a proprietary technology that helps ensure successful patient onboarding. DemoX™ is an electromechanical autoinjector training device that is designed to deliver a no-fail training experience. It delivers five times as many demo cycles (at least 1,000) as traditional training devices, so clinicians can be better equipped to provide the training their patients need and set them on the right path from the start.

At our ISO13485 certified medical division BAUMANN addresses the unique needs of customers in the medical and pharmaceutical industry. BAUMANN has the know-how to tackle the specific challenges, extraordinary standards, and strict requirements of the industry, and stand as recognized expert. To learn more, visit http://www.baumann-medical.com/

Expand your design possibilities with Celanese engineered materials and support from in-house technical experts. Our high-performance polymers and thermoplastics unlock opportunities for improving patient care with cutting-edge medical and pharmaceutical solutions. Applications include drug delivery, long-acting controlled release delivery, medical devices, orthopedics, advanced surgical instruments, connected devices and more. To learn more, visit http://www.celanese.com/

DCA is one of the world’s leading product design consultancies, with an exceptional record of developing drug delivery devices from strategy, through technical delivery, to market success. We can provide expert support for device strategy, due diligence, mechanical engineering, connectivity, medical device software, electronics, usability, industrial design, industrialisation support, packaging and instruction design. To learn more, visit https://www.dca-design.com/

DigiM provides microstructure characterization of pharmaceutical materials using high-resolution 3D micro-imaging and analysis. Our image-enabled quantification and simulations facilitate mechanistic understandings of release performance. Our analysis includes porosity, crystallinity, component distributions and sizes, and release profiles. We service long-acting parenterals and sustained-release microspheres, and a variety of non-injectable delivery technologies. Learn more at www.digimsolution.com.

FreeThink Technologies is a science-based company conducting experimental work to help clients develop drug products. FreeThink has specific expertise in stability (shelf life) and formulation development and licenses its advanced accelerated stability software ASAPprime®. FreeThink also produces OzmoCAP® extended-release capsules providing a range of release durations, independent of drug properties. For more information, visit https://freethinktech.com/

H&T Presspart is a world leader and specialist in the design, development and manufacture of drug delivery devices and pharmaceutical components. With 50 years’ experience in partnering with the world’s leading pharma companies we have developed a strong reputation for precision and reliability – critically important when patients’ quality of life depends on our products. To learn more visit www.presspart.com

Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise. The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production. For more information, visit https://hoefliger.com/en/

Haselmeier, the drug delivery device business of medmix, designs, develops and manufactures advanced drug delivery systems, such as pen injection systems and autoinjectors since more than 100 years. Patient comfort and customers’ needs are always at the heart of the company’s practices. With its broad portfolio of technologies and services, Haselmeier delivers user-friendly injection systems that enable patients to self- administer their medication reliably and accurately. Haselmeier is known for its excellent and long-standing track record of providing these innovative drug delivery devices based on its proprietary IP business model. The company collaborates closely with its customers in the pharmaceutical and biopharmaceutical industries. medmix, with its precision injection molding capabilities and expertise in liquid micro-dosing, plus financial strength and global footprint, helps Haselmeier accelerate innovation in healthcare. To learn more, please visit www.haselmeier.com

For over 80 years, we have been delivering high precision injection molds for some of the most successful metered dose inhalers, insulin pens, diagnostic products and other medical drug delivery devices around the world. Our problem-solving mindset, proven track record in the healthcare industry, considerable medical experience and meticulously methodical way of working ensures you the highest quality, process control and traceability needed for your medical products. To learn more, visit www.igsgebojagema.nl

We are an Irish R&D company, specialising in the design and development of hardware and software digital health solutions. Through the ENYA Platform, we provide configurable hardware, customizable software and support services to transform any injection device into a market-ready digital-health solution. We are attending PODD seeking global business partners. To learn more, visit innovationzed.com

Intuvie develops and manufactures infusion pumps, and drug delivery device platforms including medical device connectivity. We have recently developed a wearable, pre-fillable, drug delivery system for pharma partnerships. The Horizon II is a reusable micro-pump with a detachable, disposable drug reservoir. To learn more, visit https://www.intuvie.com/

Jabil Healthcare is the industry’s largest, most comprehensive healthcare solutions and capabilities provider — giving our customers access to an array of engineering, design, and manufacturing solutions across multiple sectors in the healthcare industry. In the face of challenging technology and value-based mandates, we are committed to customer-centric operational excellence driving positive patient outcomes. To learn more, please visit www.jabil.com

Kinneir Dufort is a design and development consultancy focused on creating value through tomorrow’s delivery systems and devices. Combining expertise in engineering, user-experience and digital, we support companies globally to improve patient adherence through customized device and packaging solutions. Our experience across the entire development process helps address new challenges, deliver on business outcomes, and create user experiences that drive demand. To learn more, please visit www.kinneirdufort.com

Lifecore Biomedical is an integrated CDMO with expertise in specialty formulation, aseptic filling, and final packaging of complex medical devices and injectable pharmaceuticals. Capabilities include: FDA-approved commercial products, highly viscous products (in excess of 100,000 cP), process development, clinical and commercial manufacturing, on-site analytical services, and pharmaceutical-grade sodium hyaluronate production. To learn more, please visit https://www.lifecore.com/

Merxin Ltd is a leading designer and supplier of inhaler devices. We make dry powder inhalers (DPIs) and soft mist inhalers (SMIs), offering drug delivery options from early evaluation through to commercial supply. MRX003 is a world leading capsule DPI; MRX004 our SMI is the preferred option for biologics molecules; MRX006 is a multidose “open-inhale-close” DPI.

We Make Inhalers. We Will Launch You. Make It Better.

www.merxin.com

info@merxin.com

Mikron Automation is your worldwide partner for advanced assembly solutions. At Mikron we are committed to delivering the best assembly systems and all needed services throughout your product’s entire life cycle. With our extensive engineering know-how, complex process expertise, scalable platforms and lifelong support we are driving lasting success for your business. To learn more, visit www.mikron.com

Noble is the global leader in medical device training solutions, patient onboarding strategies, and user-centered solutions for the world’s top pharmaceutical brands. Our mission is centered on how we can better Ideate. Validate. Educate ™ and bring the voice of the patient into our research, design, and develop of innovative products and services that provide value to our clients. For more information, visit https://www.gonoble.com/

We are a Canadian contract development and manufacturing organization (CDMO) specializing in the production of nucleic acid and lipid products that support life-enabling work. We strive towards this daily by developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing and analytical approaches, employing a highly skilled workforce, and partnering with an excellent and extensive network of relationships and collaborations. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. We are dedicated to supporting our customers by providing scalable manufacturing capacity and accelerating innovation in bringing their products from the benchtop to real-world applications.

OnDosis is an AstraZeneca spinout addressing individualized and connected treatments through its proprietary drug delivery technology for oral solid drugs. The technology enables precise and flexible dosing in the patient’s home environment through a connected handheld device with associated digital solution, also supporting adherence and remote patient monitoring. To learn more, visit https://www.ondosis.com/

Paragon Medical serves as your strategic partner in medical device manufacturing, offering an end-to-end supply chain solution from product development, to verification and validation testing, to final production, assembly, and ongoing strategic demand planning. Discover how you can experience a consistently remarkable partnership through Paragon Medical’s differentiated and personalized solutions. To learn more, please visit www.paragonmedical.com

Perdigó is a medical device design and engineering house specializing in drug delivery. This Barcelona-based firm has experience in inhalation, parenteral and ophthalmic products, and has successfully transferred designs to industry-leading contract manufacturers. Perdigó operates under an ISO13485-certified QMS, and has in-house prototyping, metrology, electronics and device verification laboratory capabilities. To learn more, please visit https://perdigo.com/

Phosphorex is a leading provider of drug delivery technologies and solutions. By harnessing the potential of microspheres and nanoparticles for drug delivery, Phosphorex offers tailored solutions and enabling technologies to optimize a drug's release rate, targeting ability, bioavailability, and deliverability, with the goal of achieving desired therapeutic effects while reducing adverse clinical outcomes. Phosphorex supports pharmaceutical and biotech companies through all phases of their development, from proof of concept to clinical studies and will be offering cGMP manufacturing services soon. Phosphorex's mission is to help our partners solve complex problems and develop successful drugs to help patients. Additional information about Phosphorex is available at www.phosphorex.com or follow us on LinkedIn.

PSN Labs is your full-service partner for engineering and product development, specializing in drug delivery solutions. From concept to commercialization, we manage every step, ensuring risk mitigation and optimization through virtual and physical processes. Our ISO 17025 Testing Lab offers biocompatibility testing, drug stability assessments, and regulatory consulting. With ISO 13485-certified molding facilities equipped with cleanroom capabilities, we streamline manufacturing and functional prototyping. Consolidating services with PSN Labs saves time, costs, and ensures the highest quality standards are met, providing a hassle-free experience for our clients. For more information, visit https://www.psnlabs.com/

R+D Custom Automation, a member of Krones Group, is a full-service automation & robotics system integrator serving the Life Sciences Industry, for over 45 years. R+D has achieved prominence by integrating proven technologies into custom & platform-based solutions, solving complex production challenges for our partners, including Medtech, Biotech and Pharmaceutical companies. To learn more please visit: https://rdcustomautomation.com/

Recipharm offers highly innovative design, development and manufacturing capabilities for injectable drug delivery devices to the global pharmaceutical market, offering a range of auto-injectors with our proprietary VapourSoft® technology. Keeping the end-user in mind, we produce auto-injectors designed to facilitate patient-friendly administration and overcome formulation challenges, particularly for high viscosity formulations. To learn more please visit: https://www.recipharm.com/

Rip Road develops and manages companion applications for biologics and medication delivery devices. We have pioneered a configurable platform for Software as Medical Device (SaMD) companion apps tailored for biologic medications. We are dedicated to elevating the patient experience, optimizing adherence, and building digital ecosystems for a connected device world. To learn more please visit: https://riproad.com/

At RPK Medical, we stand out as your long-term partner, experts in crafting tailor-made solutions in the medical device sector. Our commitment goes beyond providing solutions – we aim to transform lives for the better. We prioritize listening to you, understanding your unique needs, and tailoring solutions that go beyond springs, stamping & bending or assemblies with precision and reliability. • 50 years of expertise in creating precision customized parts for security applications • Glocal service: thinking globally, acting locally. Factories in Europe, North America and Asia • Engineering excellence, tailor made for your needs • Customized cleaning and packaging (Clean rooms in Europe, North America and Asia) • A sustainable project, your long-term partner from design to manufacturing. For more information, visit https://rpk-medical.com/en or https://rpk-global.com/medical

Scherdel Medtech is a family owned, leading global, metal component solutions provider for the medical device and drug delivery markets. We don’t just provide solutions, we provide care. To learn more, visit https://www.scherdel.com/?lang=en

SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. The portfolio comprises drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes, to cartridges, vials, and ampoules. To learn more, please visit www.schott-pharma.com

SEQENS is a worldwide leader in the development and production of active ingredients, pharmaceutical intermediates, specialty & personal care ingredients leveraging 24 manufacturing sites, 10 R&D centers and 3,400 employees in 10 countries. As an integrated player across the value chain, SEQENS develops and industrializes the most demanding molecules, and relies on its ability to innovate and implement the best available technologies. To learn more, please visit www.seqens.com

Feasibility | Design | Human Factors | Engineering | Design Transfer | Supply Shore are dynamic, progressive and a little bit different to other design firms. Partnering with the world’s largest pharma and device companies, our flexible team develop user-centred drug delivery and trainer devices, then manufacture and supply clinical volumes to worldwide locations. To learn more, visit www.shore-group.com

The unique application know-how and experience of the SOTAX Pharma Services team helps pharmaceutical companies worldwide in overcoming the various challenges associated with dissolution and release testing from pharmaceutical dosage forms. Specialized in in vitro dissolution testing, our team has a proven track record of finding the most suitable method for products ranging from APIs and tablets to implants, semi solids, and many more. Set in a US FDA-inspected facility, with a cGMP-compliant environment with strict quality management processes, the scientific expertise of our staff paired with state-of-the-art instrumentation ensures best in class services and ease of regulatory compliance for our customers. For more information, visit www.sotax.com

The SES/Force-4 team has been a leader in drug delivery technology for over 50 years. We combine deep technical knowledge and innovation to design and deliver sustainable solutions for our partners. We offer various services throughout the project lifecycle, from program management and consultation to cutting-edge technology development. To learn more, visit www.stress.com

Team Consulting is a world-class partner in medical device design and development. Working with leading pharma companies to innovative start-ups, we apply the latest approaches in design theory, engineering ingenuity and human factors to create user-centered solutions for your drug delivery needs. For more information visit https://www.team-consulting.com/

Weidmann Medical Technology AG is an independent swiss injection molding company serving the medical device and pharma industry. Its capabilities include automation, assembly and packaging; industrialisation and scale-up; quality control via in-line camera systems; high-volume plastic consumables. It has production sites with clean-room ISO Classes 7/8 in Switzerland and Mexico. To learn more, visit https://www.weidmann-medical.com/en/

Zenius is a world class one stop service provider for design, DFM, prototypes, quick-turn tooling, low-volume production and contract manufacturing offering extremely fast turnaround and exceptionally high-quality products all made in JAPAN. To learn more, visit www.zenius.jp

Biograil has developed a proprietary oral delivery technology called BIONDD™ (pronounced BEYOND). The technology fits into a standard size (00 or 0) capsule effectively delivering the active substance to the systemic circulation. Biograil team members were R&D responsible for developing the world’s first FDA approved injection molded tablet. To learn more, please visit: https://biograil.com/

Liberate Bio aims to achieve the extraordinary—delivering genetic medicines that transcend liver-based limitations, liberating patients from disease. The full potential of genetic medicines will be unlocked using generative artificial intelligence trained on high-quality, in vivo data to accelerate every aspect of creating novel, extrahepatic vehicles. Precise Delivery. Boundless Impact. For more information visit: www.liberatebio.com

Liberate Bio aims to achieve the extraordinary—delivering genetic medicines that transcend liver-based limitations, liberating patients from disease. The full potential of genetic medicines will be unlocked using generative artificial intelligence trained on high-quality, in vivo data to accelerate every aspect of creating novel, extrahepatic vehicles. Precise Delivery. Boundless Impact. For more information visit: www.liberatebio.com

Pendant Biosciences is an advanced materials biotech developing a proprietary biodegradable polymer technology utilizing cross-linked pendant functionalized polymers. This next-generation polymer system overcomes many of the limitations of older PLGA-based systems, is highly tunable and creates innovative long-acting injectable formulations for systemic and localized delivery. To learn more visit https://pendantbio.com/

Vivtex is a MIT spin off co-founded by Robert Langer of MIT. The company is developing a novel formulation-discovery platform to improve oral bioavailability of drugs that currently require needle injection. The technology is being applied in two co-development partnerships with pharma/biotech, as well as for an internal pipeline of drug candidates. To learn more, visit https://vivtex.com/

Mana.bio aims to unlock RNA therapy by developing a novel AI-based RNA delivery platform. By utilizing high throughput screening and AI, Mana created a highly efficient, ex-liver cell-specific non-viral RNA delivery solution. Mana built predictive AI models and achieved novel IP-protected in vivo results, including lung-specific delivery of mRNA.

Medicsen has developed a needle-free patch platform to deliver large molecules through painless and non-invasive ultrasounds. They have invented a miniaturized ultrasound generator and built a drug release patch system around it. It can be easily adapted to different use cases from daily small dose delivery or weekly large volume administrations. To learn more visit www.medicsen.com

Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company’s AI-driven platform, SAYER, combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles delivering a broad range of genetic cargoes with tissue specificity. For more information, visit: https://www.nanitebio.com/

Nosis Bio develops cell-targeted delivery vehicles for the extrahepatic delivery of genetic medicines. Nosis delivery vehicles have been validated for functional delivery to multiple tissue and cell types and are compatible with both systemic and local routes of administration. Nosis partners with some of the world’s leading biotechs to accelerate delivery to novel tissues and develops their own internal pipeline of therapeutics. To learn more, please visit www.nosisbio.com

pacDNA LLC is revolutionizing oligonucleotide therapeutics through our groundbreaking Brushield™ oligonucleotide delivery technology. With Brushield™, we have unlocked the potential to rapidly develop potent clinical leads with significantly reduced side effects and dosage requirements. Our platform enables delivery to non-liver sites, enhances treatment durability, and minimizes toxicity/immunogenicity. To discover more about our transformative approach, visit www.pacdnatx.com

Our goal is to accelerate pre-clinical development time for long-acting injectables through automation and machine learning. This reduces time-to-market for our pharma customers and enables them to improve patient compliance & quality-of-life. Persist is currently seeking collaborators who’d like a formulation for their API, as a case-study. To learn more, please visit https://www.persist-ai.com/

Piezo Therapeutics aims to transform the delivery of nucleic acid medicines to enable improved safety, efficacy, affordability, and scalability. Piezo is developing a uniquely engineered platform that uses electric pulses and microneedles to deliver a broad range of therapeutics inside the body and is simple, cost-effective, and rapid to produce at scale. To learn more please visit: www.piezotx.com

SpheroFill is developing an innovative drug delivery platform based on porous-wall hollow glass microspheres (PWHGMs). This novel class of materials enable distinctive features including sustained or programmed release, protecting labile biologic drugs, taste elimination, and allowing solid drugs to be handled as liquids thus enabling titration for accurate weight-based dosing. To learn more please visit: www.spherofill.net